Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

Phase III trial comparing local control and side effects after fractionated stereotactic radiotherapy and single session radiosurgery in patients with larger brain metastases (2-4 cm)

Trial Details

NCT ID
NCT03697343
Phase
PHASE3
Sponsor
University of Erlangen-Nürnberg Medical School
Status
RECRUITING
Cancer Type
Brain Cancer
Locations (sample)
  • Stuttgart, Baden-Wurttemberg, Germany
  • Bayreuth, Bavaria, Germany
  • Coburg, Bavaria, Germany
  • Hof, Bavaria, Germany
  • Kempten (Allgäu), Bavaria, Germany

Key Eligibility Criteria

  • Age \> 18 years, no upper age limit
  • Karnofsky Performance Score \> 50 points
  • Expected Survival \> 3 months
  • 1-10 cerebral metastases of metastatic solid cancer

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Brain Cancer Trials on Trialify →